With various studies predicting the global market for GLP-1s exceeding a staggering $471 billion by 2032, employers should be asking: What is my strategy for achieving an ROI for the spend on these expensive weight loss medications? In the U.S. alone …

Early discontinuation of medications happens for various reasons – and for the increasingly popular GLP-1 medications, they include supply chain issues, cost and intolerable side effects ranging from nausea and diarrhea to more severe complications l …

DALLAS, TX – Change in the employee benefits space is a given. Companies that work with insurance brokers and consultants always have questions. So, it’s important to know which questions to ask and how to frame them to find the right broker/consulta …